|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2009-7-21
|
|
pubmed:abstractText |
The purpose of the study was to determine the role of fecal calprotectin and lactoferrin in the prediction of inflammatory bowel disease relapses, both in patients with ulcerative colitis (UC) and Crohn's disease (CD), in a large, long-term, follow-up study.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1536-4844
|
|
pubmed:author |
pubmed-author:AlgabaAliciaA,
pubmed-author:BermejoFernandoF,
pubmed-author:CalvoMartaM,
pubmed-author:CarnerosJose-AntonioJA,
pubmed-author:GisbertJavier PJP,
pubmed-author:González-LamaYagoY,
pubmed-author:López-PalaciosNataliaN,
pubmed-author:LópezPilarP,
pubmed-author:MatéJoséJ,
pubmed-author:McNichollAdrian GAG,
pubmed-author:Pérez-CalleJose-LázaroJL,
pubmed-author:TaxoneraCarlosC,
pubmed-author:VelascoMartaM,
pubmed-author:VeraIsabelI
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1190-8
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:19291780-Adult,
pubmed-meshheading:19291780-Biological Markers,
pubmed-meshheading:19291780-Case-Control Studies,
pubmed-meshheading:19291780-Colitis, Ulcerative,
pubmed-meshheading:19291780-Crohn Disease,
pubmed-meshheading:19291780-Feces,
pubmed-meshheading:19291780-Female,
pubmed-meshheading:19291780-Follow-Up Studies,
pubmed-meshheading:19291780-Humans,
pubmed-meshheading:19291780-Lactoferrin,
pubmed-meshheading:19291780-Leukocyte L1 Antigen Complex,
pubmed-meshheading:19291780-Male,
pubmed-meshheading:19291780-Prognosis,
pubmed-meshheading:19291780-Prospective Studies,
pubmed-meshheading:19291780-Recurrence,
pubmed-meshheading:19291780-Remission Induction
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse.
|
|
pubmed:affiliation |
Gastroenterology Unit, Hospital Universitario de la Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain. gisbert@meditex.es
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
